Endostar for Locally Recurrent Nasopharyngeal Carcinoma
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether endostar and IMRT is effective in the
treatment of locally recurrent nasopharyngeal carcinoma patients compared with IMRT alone.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University Cancer Center of Guangzhou Medical University First People's Hospital of Foshan JiangXi Province Tumor Hospital Second Affiliated Hospital of Nanchang University The Affiliated Ganzhou Hospital of Nanchang University The First Affiliated Hospital of Clinical Medicine of G.D.P.U. The First Hospital of Gannan Medical University